Vectors Research Management’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Buy
3,117
+432
+16% +$249K 0.41% 69
2026
Q1
$1.83M Buy
2,685
+5
+0.2% +$3.46K 0.54% 59
2025
Q4
$1.53M Buy
2,680
+22
+0.8% +$12.8K 0.47% 61
2025
Q3
$1.62M Buy
2,658
+35
+1% +$19.8K 0.51% 57
2025
Q2
$1.31M Sell
2,623
-75
-3% -$36.9K 0.45% 59
2025
Q1
$1.38M Buy
2,698
+44
+2% +$21K 0.48% 57
2024
Q4
$1.25M Sell
2,654
-166
-6% -$83.5K 0.42% 62
2024
Q3
$1.49M Sell
2,820
-79
-3% -$38.7K 0.45% 62
2024
Q2
$1.26M Sell
2,899
-42
-1% -$19.2K 0.39% 66
2024
Q1
$1.41M Buy
2,941
+1,575
+115% +$725K 0.4% 69
2023
Q4
$640K Buy
+1,366
New +$640K 0.18% 98
2022
Q3
Sell
-5
Closed -$2K 361
2022
Q2
$2K Hold
5
﹤0.01% 470
2022
Q1
$2K Hold
5
﹤0.01% 438
2021
Q4
$2K Buy
+5
New +$1.86K ﹤0.01% 558

Other funds holding NOC

Vectors Research Management's NOC Position: Q2 2026 in Review

Vectors Research Management increased its Northrop Grumman (NOC) stake by 16% in Q2 2026, buying an estimated $249K and bringing the position to 3,117 shares worth $1.59M. The position accounts for 0.41% of the portfolio, ranked #69.

Vectors Research Management first reported a position in NOC in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.83M in Q1 2026. 1,802 funds tracked by Wall St. Rank hold NOC as of Q2 2026.

  • Vectors Research Management held 3,117 shares of Northrop Grumman worth $1.59M as of Q2 2026.
  • Vectors Research Management bought 432 Northrop Grumman shares in Q2 2026, an estimated $249K.
  • Northrop Grumman made up 0.41% of Vectors Research Management's portfolio in Q2 2026, its #69 holding.
  • Vectors Research Management first reported a position in Northrop Grumman in Q4 2021 and has held it in 14 quarters since.
  • Vectors Research Management's Northrop Grumman position peaked at $1.83M in Q1 2026.
  • 1,802 funds tracked by Wall St. Rank held Northrop Grumman as of Q2 2026.

Based on Vectors Research Management's 13F filing for Q2 2026, filed 29 Jul 2026.